Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-wg55d Total loading time: 0 Render date: 2024-05-29T23:52:59.275Z Has data issue: false hasContentIssue false

Chapter 12 - Movement disorders in renal diseases

from Section II - Movement disorders in systemic disease

Published online by Cambridge University Press:  05 April 2014

By
Tiago Teodoro  and
Joaquim J. Ferreira
Edited by
Werner Poewe  and
Joseph Jankovic
Tiago Teodoro
Affiliation:
Neurological Clinical Research Unit, Instituto de Medicina Molecular, Lisbon, Portugal
Joaquim J. Ferreira
Affiliation:
Neurological Clinical Research Unit, Instituto de Medicina Molecular, and Laboratory of Clinical Pharmacology & Therapeutics, Faculty of Medicine, University of Lisbon, Portugal
Werner Poewe
Affiliation:
Medical University Innsbruck
Joseph Jankovic
Affiliation:
Baylor College of Medicine, Texas
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Movement Disorders in Neurologic and Systemic Disease , pp. 172 - 188
Publisher: Cambridge University Press
Print publication year: 2014

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Adams, R. D. and Foley, J. M. (1949). “The neurological changes in the more common types of severe liver disease,” Trans American Neurology Association 74: 217–19.Google Scholar
Agildere, A. M., Benli, S., Erten, Y., Coskun, M., Boyvat, F., and Ozdemir, N. (1998). “Osmotic demyelination syndrome with a dysequilibrium syndrome: reversible MRI findings,” Neuroradiology 40(4): 228–32.Google ScholarPubMed
Agildere, A. M., Kurt, A., Yildirim, T., Benli, S., and Altinors, N. (2001). “MRI of neurologic complications in end-stage renal failure patients on hemodialysis: pictorial review,” Eur. Radiol. 11(6): 1063–9.CrossRefGoogle ScholarPubMed
Alfrey, A. C., Mishell, J. M., Burks, J., Contiguglia, S. R., Rudolph, H., Lewin, E., et al. (1972). “Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis,” Trans Am. Soc. Artif. Intern. Organs 18(0): 257–61, 66–7.CrossRefGoogle Scholar
Aminoff, M. J. (2007). “Neurologic dysfunction and kidney disease,” in Aminoff, M. J., Neurology and General Medicine, 4th edn. (Philadelphia, PA: Churchill Livingstone/Elsevier).Google Scholar
Andermann, E., Andermann, F., Carpenter, S., Wolfe, L. S., Nelson, R., Patry, G., et al. (1986). “Action myoclonus-renal failure syndrome: a previously unrecognized neurological disorder unmasked by advances in nephrology,” Adv. Neurol. 43: 87–103.Google ScholarPubMed
Araujo, S. M., de Bruin, V. M., Nepomuceno, L. A., Maximo, M. L., Daher Ede, F., Correia Ferrer, D. P., et al. (2010). “Restless legs syndrome in end-stage renal disease: clinical characteristics and associated comorbidities,” Sleep Med. 11(8): 785–90.CrossRefGoogle ScholarPubMed
Arieff, A. I. (2004). “Neurologic complications of renal insufficiency” in Brenner, B. M. (ed.), Brenner & Rector’s The Kidney, 7th edn. (Philadelphia, PA: Elsevier/Saunders).Google Scholar
Arieff, A. I. and Massry, S. G. (1974). “Calcium metabolism of brain in acute renal failure. Effects of uremia, hemodialysis, and parathyroid hormone,” J. Clin. Invest. 53(2): 387–92.CrossRefGoogle ScholarPubMed
Ausserwinkler, M. and Schmidt, P. (1989). “Successful clonidine treatment of restless legs syndrome in chronic kidney insufficiency,” Schweiz Med. Wochenschr. 119(6): 184–6.Google ScholarPubMed
Azizi, E., Eshel, G., and Aladjem, M. (1989). “Hypercalciuria and nephrolithiasis as a presenting sign in Wilson disease,” Eur. J. Pediatr. 148(6): 548–9.CrossRefGoogle ScholarPubMed
Baba, Y., Higuchi, M. A., Fukuyama, K., Abe, H., Uehara, Y., Inoue, T., et al. (2011). “Effect of chronic kidney disease on excessive daytime sleepiness in Parkinson disease,” Eur. J. Neurol. 18(11): 1299–303.CrossRefGoogle ScholarPubMed
Badhwar, A., Berkovic, S. F., Dowling, J. P., Gonzales, M., Narayanan, S., Brodtmann, A., et al. (2004). “Action myoclonus-renal failure syndrome: characterization of a unique cerebro-renal disorder,” Brain 127(Pt. 10): 2173–82.CrossRefGoogle ScholarPubMed
Bakir, A. A., Hryhorczuk, D. O., Berman, E., and Dunea, G. (1986). “Acute fatal hyperaluminemic encephalopathy in undialyzed and recently dialyzed uremic patients,” ASAIO Trans. 32(1): 171–6.Google ScholarPubMed
Balreira, A., Gaspar, P., Caiola, D., Chaves, J., Beirao, I., Lima, J. L., et al. (2008). “A nonsense mutation in the LIMP-2 gene associated with progressive myoclonic epilepsy and nephrotic syndrome,” Hum. Mol. Genet. 17(14): 2238–43.CrossRefGoogle ScholarPubMed
Bataller, L., Graus, F., Saiz, A., and Vilchez, J. J. (2001). “Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus,” Brain 124(Pt. 2): 437–43.CrossRefGoogle ScholarPubMed
Berkovic, S. F., Dibbens, L. M., Oshlack, A., Silver, J. D., Katerelos, M., Vears, D. F., et al. (2008). “Array-based gene discovery with three unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis,” Am. J. Hum. Genet. 82(3): 673–84.CrossRefGoogle ScholarPubMed
Berlyne, G. M., Ben-Ari, J., Pest, D., Weinberger, J., Stern, M., Levine, R., et al. (1970). “Hyperaluminaemia from aluminum resins in renal failure,” Lancet Neurol. 2(7671): 494–6.CrossRefGoogle ScholarPubMed
Betz, R., Rensing, C., Otto, E., Mincheva, A., Zehnder, D., Lichter, P., et al. (2000). “Children with ocular motor apraxia type Cogan carry deletions in the gene (NPHP1) for juvenile nephronophthisis,” J. Pediatr. 136(6): 828–31.Google ScholarPubMed
Brown, P. (2004). “Action myoclonus-renal failure syndrome: the definitive clinico-pathological description,” Brain 127(Pt. 10): 2151–2.CrossRefGoogle ScholarPubMed
Burn, D. J. and Bates, D. (1998). “Neurology and the kidney,” J. Neurol. Neurosurg. Psychiatry 65(6): 810–21.CrossRefGoogle ScholarPubMed
Calne, D. B., Chu, N. S., Huang, C. C., Lu, C. S., and Olanow, W. (1994). “Manganism and idiopathic parkinsonism: similarities and differences,” Neurology 44(9): 1583–6.CrossRefGoogle ScholarPubMed
Caridi, G., Dagnino, M., Rossi, A., Valente, E. M., Bertini, E., Fazzi, E., et al. (2006). “Nephronophthisis type 1 deletion syndrome with neurological symptoms: prevalence and significance of the association,” Kidney Int. 70(7): 1342–7.CrossRefGoogle ScholarPubMed
Caridi, G., Murer, L., Bellantuono, R., Sorino, P., Caringella, D. A., Gusmano, R., et al. (1998). “Renal-retinal syndromes: association of retinal anomalies and recessive nephronophthisis in patients with homozygous deletion of the NPH1 locus,” Am. J. Kidney Dis. 32(6): 1059–62.CrossRefGoogle ScholarPubMed
Cavanaugh, J. J. and Finlayson, R. E. (1984). “Rhabdomyolysis due to acute dystonic reaction to antipsychotic drugs,” J. Clin. Psychiatry 45(8): 356–7.Google ScholarPubMed
Chadwick, D. and French, A. T. (1979). “Uraemic myoclonus: an example of reticular reflex myoclonus?” J. Neurol. Neurosurg. Psychiatry 42(1): 52–5.CrossRefGoogle ScholarPubMed
Chamouard, J. M., Smagghe, A., Malalanirina, B. H., Davous, P., and Poisson, M. (1992). “Chorea disclosing polycythemia and renal adenocarcinoma,” Rev. Neurol. (Paris) 148(5): 380–2.Google ScholarPubMed
Chaves, J., Beirao, I., Balreira, A., Gaspar, P., Caiola, D., Sa-Miranda, M. C., et al. (2011). “Progressive myoclonus epilepsy with nephropathy C1q due to SCARB2/LIMP-2 deficiency: clinical report of two siblings,” Seizure 20(9): 738–40.CrossRefGoogle ScholarPubMed
Cupidi, C., Piccoli, F., and La Bella, V. (2006). “Acute reversible parkinsonism in a diabetic-uremic patient,” Clin. Neurol. Neurosurg. 108(6): 601–3.CrossRefGoogle Scholar
da Silva, C. J., da Rocha, A. J., Jeronymo, S., Mendes, M. F., Milani, F. T., Maia, A. C., et al. (2007). “A preliminary study revealing a new association in patients undergoing maintenance hemodialysis: manganism symptoms and T1 hyperintense changes in the basal ganglia,” AJNR Am. J. Neuroradiol. 28(8): 1474–9.CrossRefGoogle ScholarPubMed
Davison, A. M., Walker, G. S., Oli, H., and Lewins, A. M. (1982). “Water supply aluminium concentration, dialysis dementia, and effect of reverse-osmosis water treatment,” Lancet Neurol. 2(8302): 785–7.Google ScholarPubMed
De Deyn, P. P., D’Hooge, R., Van Bogaert, P. P., and Marescau, B. (2001). “Endogenous guanidino compounds as uremic neurotoxins,” Kidney Int. Suppl. 78: S77–83.CrossRefGoogle ScholarPubMed
De Luca, S., Terrone, C., Crivellaro, S., De Zan, A., Polo, P., Vigliani, M. C., et al. (2002). “Opsoclonus-myoclonus syndrome as a paraneoplastic manifestation of renal cell carcinoma. a case report and review of the literature,” Urol. Int. 68(3): 206–8.CrossRefGoogle ScholarPubMed
de Oliveira, M. M., Conti, C. F., Valbuza, J. S., de Carvalho, L. B., and do Prado, G. F. (2010). “The pharmacological treatment for uremic restless legs syndrome: evidence-based review,” Mov. Disord. 25(10): 1335–42.CrossRefGoogle ScholarPubMed
D’Hooge, R., Pei, Y. Q., Manil, J., and De Deyn, P. P. (1992). “The uremic guanidino compound guanidinosuccinic acid induces behavioral convulsions and concomitant epileptiform electrocorticographic discharges in mice,” Brain Res. 598(1–2): 316–20.CrossRefGoogle ScholarPubMed
D’Hooge, R., Pei, Y. Q., Marescau, B., and De Deyn, P. P. (1992). “Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice,” J. Neurol. Sci. 112(1–2): 96–105.CrossRefGoogle ScholarPubMed
Dibbens, L. M., Michelucci, R., Gambardella, A., Andermann, F., Rubboli, G., Bayly, M. A., et al. (2009). “SCARB2 mutations in progressive myoclonus epilepsy (PME) without renal failure,” Ann. Neurol. 66(4): 532–6.CrossRefGoogle ScholarPubMed
Dicuonzo, F., Di Fede, R., Salvati, A., Palma, M., de Mari, M., Baldassarre, G. D., et al. (2010). “Acute extrapyramidal disorder with bilateral reversible basal ganglia lesions in a diabetic uremic patient: diffusion-weighted imaging and spectroscopy findings,” J. Neurol. Sci. 293(1–2): 119–21.CrossRefGoogle Scholar
Dunea, G. (2001). “Dialysis dementia: an epidemic that came and went,” ASAIO J. 47(3): 192–4.CrossRefGoogle ScholarPubMed
Enomoto, M., Inoue, Y., Namba, K., Munezawa, T., and Matsuura, M. (2008). “Clinical characteristics of restless legs syndrome in end-stage renal failure and idiopathic RLS patients,” Mov. Disord. 23(6): 811–16; quiz 926.CrossRefGoogle ScholarPubMed
Fraser, C. L. and Arieff, A. I. (1988). “Nervous system complications in uremia,” Ann. Intern. Med. 109(2): 143–53.CrossRefGoogle ScholarPubMed
Fraser, C. L., Sarnacki, P., and Arieff, A. I. (1985). “Abnormal sodium transport in synaptosomes from brain of uremic rats,” J. Clin. Invest. 75(6): 2014–23.CrossRefGoogle ScholarPubMed
Fraser, C. L., Sarnacki, P., and Arieff, A. I. (1985). “Calcium transport abnormality in uremic rat brain synaptosomes,” J. Clin. Invest. 76(5): 1789–95.CrossRefGoogle ScholarPubMed
Gigli, G. L., Adorati, M., Dolso, P., Piani, A., Valente, M., Brotini, S., et al. (2004). “Restless legs syndrome in end-stage renal disease,” Sleep Med. 5(3): 309–15.CrossRefGoogle ScholarPubMed
Gimeno Campos, M. J., Sanchis Minguez, C., Diez de Diego, P., and Sanchez Villasante, J. (2006). “Opsoclonus-myoclonus: paraneoplastic syndrome associated with renal adenocarcinoma,” Rev. Esp. Anestesiol. Reanim. 53(1): 54–5.Google ScholarPubMed
Holmberg, C., Antikainen, M., Ronnholm, K., Ala Houhala, M., and Jalanko, H. (1995). “Management of congenital nephrotic syndrome of the Finnish type,” Pediatr. Nephrol. 9(1): 87–93.CrossRefGoogle ScholarPubMed
Hopfner, F., Schormair, B., Knauf, F., Berthele, A., Tolle, T. R., Baron, R., et al. (2011). “Novel SCARB2 mutation in action myoclonus-renal failure syndrome and evaluation of SCARB2 mutations in isolated AMRF features,” BMC Neurol. 11: 134.CrossRefGoogle ScholarPubMed
Hoppe, B., Neuhaus, T., Superti-Furga, A., Forster, I., and Leumann, E. (1993). “Hypercalciuria and nephrocalcinosis, a feature of Wilson’s disease,” Nephron. 65(3): 460–2.CrossRefGoogle ScholarPubMed
Hosokawa, S., Oyamaguchi, A., and Yoshida, O. (1990). “Trace elements and complications in patients undergoing chronic hemodialysis,” Nephron. 55(4): 375–9.CrossRefGoogle ScholarPubMed
Huang, C. C., Chu, N. S., Lu, C. S., Chen, R. S., Schulzer, M., and Calne, D. B. (2007). “The natural history of neurological manganism over 18 years,” Parkinsonism Relat. Disord. 13(3): 143–5.CrossRefGoogle ScholarPubMed
Hui, D. S., Wong, T. Y., Ko, F. W., Li, T. S., Choy, D. K., Wong, K. K., et al. (2000). “Prevalence of sleep disturbances in Chinese patients with end-stage renal failure on continuous ambulatory peritoneal dialysis,” Am. J. Kidney Dis. 36(4): 783–8.CrossRefGoogle ScholarPubMed
Hung, S. C., Hung, S. H., Tarng, D. C., Yang, W. C., and Huang, T. P. (2001). “Chorea induced by thiamine deficiency in hemodialysis patients,” Am. J. Kidney Dis. 37(2): 427–30.CrossRefGoogle ScholarPubMed
Hung, S. C., Hung, S. H., Tarng, D. C., Yang, W. C., Chen, T. W., and Huang, T. P. (2001). “Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients,” Am. J. Kidney Dis. 38(5): 941–7.CrossRefGoogle ScholarPubMed
Jagadha, V., Deck, J. H., Halliday, W. C., and Smyth, H. S. (1987). “Wernicke’s encephalopathy in patients on peritoneal dialysis or hemodialysis,” Ann. Neurol. 21(1): 78–84.CrossRefGoogle ScholarPubMed
Jankovic, J. (1986). “Myoglobinuric renal failure in Huntington’s chorea,” Neurology 36(1): 138–9.CrossRefGoogle ScholarPubMed
Jankovic, J. and Penn, A. S. (1982). “Severe dystonia and myoglobinuria,” Neurology 32(10): 1195–7.CrossRefGoogle ScholarPubMed
Josephs, K. A., Ahlskog, J. E., Klos, K. J., Kumar, N., Fealey, R. D., Trenerry, M. R., et al. (2005). “Neurologic manifestations in welders with pallidal MRI T1 hyperintensity,” Neurology 64(12): 2033–9.CrossRefGoogle ScholarPubMed
Kalra, V., Mahajan, S., and Kesarwani, P. K. (2004). “Rare presentation of Wilson’s disease: a case report,” Int. Urol. Nephrol. 36(2): 289–91.CrossRefGoogle ScholarPubMed
Kim, T. K., Seo, S. I., Kim, J. H., Lee, N. J., and Seol, H. Y. (2006). “Diffusion-weighted magnetic resonance imaging in the syndrome of acute bilateral basal ganglia lesions in diabetic uremia,” Mov. Disord. 21(8): 1267–70.CrossRefGoogle ScholarPubMed
Kiryluk, K., Khan, F., and Valeri, A. (2008). “Acute chorea and bilateral basal ganglia lesions in a hemodialysis patient,” Kidney Int. 73(9): 1087–91.CrossRefGoogle Scholar
Koukoulis, A., Cimas, I., and Gomara, S. (1998). “Paraneoplastic opsoclonus associated with papillary renal cell carcinoma,” J. Neurol. Neurosurg. Psychiatry 64(1): 137–8.CrossRefGoogle ScholarPubMed
Kujawa, K. A., Niemi, V. R., Tomasi, M. A., Mayer, N. W., Cochran, E., and Goetz, C. G. (2001). “Ballistic-choreic movements as the presenting feature of renal cancer,” Arch. Neurol. 58(7): 1133–5.CrossRefGoogle ScholarPubMed
Laakkonen, H., Lonnqvist, T., Uusimaa, J., Qvist, E., Valanne, L., Nuutinen, M., et al. (2006). “Muscular dystonia and athetosis in six patients with congenital nephrotic syndrome of the Finnish type (NPHS1),” Pediatr. Nephrol. 21(2): 182–9.CrossRefGoogle Scholar
Lazarus, A. L. and Toglia, J. U. (1985). “Fatal myoglobinuric renal failure in a patient with tardive dyskinesia,” Neurology 35(7): 1055–7.CrossRefGoogle Scholar
Lee, E. J., Park, J. H., Ihn, Y., Kim, Y. J., Lee, S. K., and Park, C. S. (2007). “Acute bilateral basal ganglia lesions in diabetic uraemia: diffusion-weighted MRI,” Neuroradiology 49(12): 1009–13.CrossRefGoogle ScholarPubMed
Lee, P. H., Shin, D. H., Kim, J. W., Song, Y. S., and Kim, H. S. (2006). “Parkinsonism with basal ganglia lesions in a patient with uremia: evidence of vasogenic edema,” Parkinsonism Relat. Disord. 12(2): 93–6.CrossRefGoogle Scholar
Lee, Y. H. (2005). “Diabetic nephropathy with acute symmetrical changes in the basal ganglia regions,” Clin. Radiol. 60(7): 815–20.CrossRefGoogle ScholarPubMed
Leschziner, G. and Gringras, P. (2012). “Restless legs syndrome,” BMJ 344: e3056.CrossRefGoogle ScholarPubMed
Leu, M. L., Strickland, G. T., and Gutman, R. A. (1970). “Renal function in Wilson’s disease: response to penicillamine therapy,” Am. J. Med. Sci. 260(6): 381–98.CrossRefGoogle ScholarPubMed
Li, J. Y., Yong, T. Y., Sebben, R., Khoo, E., and Disney, A. P. (2008). “Bilateral basal ganglia lesions in patients with end-stage diabetic nephropathy,” Nephrology (Carlton) 13(1): 68–72.CrossRefGoogle ScholarPubMed
Lin, H. L., Lin, H. C., and Chen, Y. H. (2012). “Increased risks of parkinsonism in the 3 years after chronic renal failure,” Int. J. Clin. Pract. 66(5): 499–503.CrossRefGoogle ScholarPubMed
Lin, J. J. (2011). “Generalized chorea in the syndrome of acute bilateral basal ganglia lesions in patients with diabetic uremia,” J. Clin. Neurosci. 18(9): 1266–8.CrossRefGoogle ScholarPubMed
Litin, R. B., Randall, R. V., Goldstein, N. P., Power, M. H., and Diessner, G. R. (1959). “Hypercalciuria in hepatolenticular degeneration (Wilson’s disease),” Am. J. Med. Sci. 238: 614–20.CrossRefGoogle Scholar
Lui, W. Y. (1979). “Phenothiazine-induced dystonia associated with an increase in serum creatine phosphokinase,” Arch. Dis. Child. 54(2): 150–1.CrossRefGoogle ScholarPubMed
Massey, E. W., Bowman, M. H., and Rozear, M. P. (1988). “Asterixis mimicking drop attacks in chronic renal failure,” Neurology 38(4): 663.CrossRefGoogle ScholarPubMed
McDermott, J. R., Smith, A. I., Ward, M. K., Parkinson, I. S., and Kerr, D. N. (1978). “Brain-aluminium concentration in dialysis encephalopathy,” Lancet Neurol. 1(8070): 901–4.CrossRefGoogle ScholarPubMed
McKinney, A. M., Filice, R. W., Teksam, M., Casey, S., Truwit, C., Clark, H. B., et al. (2004). “Diffusion abnormalities of the globi pallidi in manganese neurotoxicity,” Neuroradiology 46(4): 291–5.CrossRefGoogle ScholarPubMed
Mena, I., Marin, O., Fuenzalida, S., and Cotzias, G. C. (1967). “Chronic manganese poisoning. Clinical picture and manganese turnover,” Neurology 17(2): 128–36.CrossRefGoogle ScholarPubMed
Merlino, G., Gigli, G. L., and Valente, M. (2008). “Sleep disturbances in dialysis patients,” J. Nephrol. 21(Suppl. 13): S66–70.Google ScholarPubMed
Miranda, M., Kagi, M., Fabres, L., Aguilera, L., Alvo, M., Elgueta, L., et al. (2004). “Pramipexole for the treatment of uremic restless legs in patients undergoing hemodialysis,” Neurology 62(5): 831–2.CrossRefGoogle ScholarPubMed
Morita, T., Kotani, H., Ishihara, M., Naruse, K., Fujieda, M., Wakiguchi, H., et al. (2007). “Renal complications in two patients with dentatorubral-pallidoluysian atrophy,” Clin. Nephrol. 67(1): 44–8.CrossRefGoogle ScholarPubMed
Nelson, K., Golnick, J., Korn, T., and Angle, C. (1993). “Manganese encephalopathy: utility of early magnetic resonance imaging,” Br. J. Ind. Med. 50(6): 510–13.Google ScholarPubMed
Nzwalo, H., Sa, F., Capela, C., Ferreira, F., and Basilio, C. (2012). “Reversible acute parkinsonism and bilateral basal ganglia lesions in a diabetic uremic patient,” Case Rep. Neurol. 4(3): 156–8.CrossRefGoogle Scholar
Oh, S. H., Lee, K. Y., Im, J. H., and Lee, M. S. (2002). “Chorea associated with non-ketotic hyperglycemia and hyperintensity basal ganglia lesion on T1-weighted brain MRI study: a meta-analysis of 53 cases including four present cases,” J. Neurol. Sci. 200(1–2): 57–62.CrossRefGoogle ScholarPubMed
Ohayon, M. M., O’Hara, R., and Vitiello, M. V. (2012). “Epidemiology of restless legs syndrome: a synthesis of the literature,” Sleep Med. Rev. 16(4): 283–95.CrossRefGoogle ScholarPubMed
Ohtake, T., Negishi, K., Okamoto, K., Oka, M., Maesato, K., Moriya, H., et al. (2005). “Manganese-induced Parkinsonism in a patient undergoing maintenance hemodialysis,” Am. J. Kidney Dis. 46(4): 749–53.CrossRefGoogle Scholar
Okada, J., Yoshikawa, K., Matsuo, H., Kanno, K., and Oouchi, M. (1991). “Reversible MRI and CT findings in uremic encephalopathy,” Neuroradiology 33(6): 524–6.CrossRefGoogle ScholarPubMed
Ono, S., Kaneda, K., Suzuki, M., Tagawa, A., and Shimizu, N. (2002). “Dentatorubro pallidoluysian atrophy with chronic renal failure in a Japanese family,” Eur. Neurol. 47(4): 222–3.CrossRefGoogle Scholar
Pan, J. C., Pei, Y. Q., An, L., Lai, L., D’Hooge, R., and De Deyn, P. P. (1996). “Epileptiform activity and hippocampal damage produced by intrahippocampal injection of guanidinosuccinic acid in rat,” Neurosci. Lett. 209(2): 121–4.CrossRefGoogle ScholarPubMed
Paret, G., Tirosh, R., Ben-Zeev, B., Vardi, A., Brandt, N., and Barzilay, Z. (1995). “Rhabdomyolysis due to hereditary torsion dystonia,” Pediatr. Neurol. 13(1): 83–4.CrossRefGoogle ScholarPubMed
Park, J. H., Kim, H. J., and Kim, S. M. (2007). “Acute chorea with bilateral basal ganglia lesions in diabetic uremia,” Can. J. Neurol. Sci. 34(2): 248–50.CrossRefGoogle ScholarPubMed
Pellecchia, M. T., Vitale, C., Sabatini, M., Longo, K., Amboni, M., Bonavita, V., et al. (2004). “Ropinirole as a treatment of restless legs syndrome in patients on chronic hemodialysis: an open randomized crossover trial versus levodopa sustained release,” Clin. Neuropharmacol. 27(4): 178–81.CrossRefGoogle ScholarPubMed
Pierratos, A. and Hanly, P. J. (2011). “Sleep disorders over the full range of chronic kidney disease,” Blood Purif. 31(1–3): 146–50.CrossRefGoogle ScholarPubMed
Pieta, J., Millar, T., Zacharias, J., Fine, A., and Kryger, M. (1998). “Effect of pergolide on restless legs and leg movements in sleep in uremic patients,” Sleep 21(6): 617–22.CrossRefGoogle ScholarPubMed
Raskin, N. H. and Fishman, R. A. (1976). “Neurologic disorders in renal failure (first of two parts),” N. Engl. J. Med. 294(3): 143–8.CrossRefGoogle Scholar
Reczek, D., Schwake, M., Schroder, J., Hughes, H., Blanz, J., Jin, X., et al. (2007). “LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase,” Cell 131(4): 770–83.CrossRefGoogle ScholarPubMed
Rob, P. M., Niederstadt, C., and Reusche, E. (2001). “Dementia in patients undergoing long-term dialysis: aetiology, differential diagnoses, epidemiology and management,” CNS Drugs 15(9): 691–9.CrossRefGoogle ScholarPubMed
Russo, L. S., Beale, G., Sandroni, S., and Ballinger, W. E. (1992). “Aluminium intoxication in undialysed adults with chronic renal failure,” J. Neurol. Neurosurg. Psychiatry 55(8): 697–700.CrossRefGoogle ScholarPubMed
Sandyk, R., Bernick, C., Lee, S. M., Stern, L. Z., Iacono, R. P., and Bamford, C. R. (1987). “L-dopa in uremic patients with the restless legs syndrome,” Int. J. Neurosci. 35(3–4): 233–5.CrossRefGoogle ScholarPubMed
Schabowski, J., Ksiazek, A., Paprzycki, P., and Skrzydlo-Radomanska, B. (1994). “Ferrum, copper, zinc and manganese in tissues of patients treated with long-standing hemodialysis programme,” Ann. Univ. Mariae Curie Sklodowska Med. 49: 61–6.Google ScholarPubMed
Sheu, Y. L., Cheng, S. J., Chen, Y. M., and Hseuh, I. H. (2007). “The syndrome of bilateral basal ganglia lesions in diabetic uremic patients presenting with a relapsing and remitting course: a case report,” Acta Neurol. Taiwan 16(4): 226–30.Google ScholarPubMed
Trenkwalder, C., Stiasny, K., Pollmacher, T., Wetter, T., Schwarz, J., Kohnen, R., et al. (1995). “L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial,” Sleep 18(8): 681–8.CrossRefGoogle ScholarPubMed
Thorp, M. L., Morris, C. D., and Bagby, S. P. (2001). “A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients,” Am. J. Kidney Dis. 38(1): 104–8.CrossRefGoogle ScholarPubMed
Unruh, M. L., Levey, A. S., D’Ambrosio, C., Fink, N. E., Powe, N. R., and Meyer, K. B. (2004). “Restless legs symptoms among incident dialysis patients: association with lower quality of life and shorter survival,” Am. J. Kidney Dis. 43(5): 900–9.CrossRefGoogle ScholarPubMed
Vadlamudi, L., Vears, D. F., Hughes, A., Pedagogus, E., and Berkovic, S. F. (2006). “Action myoclonus-renal failure syndrome: a cause for worsening tremor in young adults,” Neurology 67(7): 1310–11.CrossRefGoogle ScholarPubMed
Vernino, S., Tuite, P., Adler, C. H., Meschia, J. F., Boeve, B. F., Boasberg, P., et al. (2002). “Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma,” Ann. Neurol. 51(5): 625–30.CrossRefGoogle ScholarPubMed
Vigliani, M. C., Honnorat, J., Antoine, J. C., Vitaliani, R., Giometto, B., Psimaras, D., et al. (2011). “Chorea and related movement disorders of paraneoplastic origin: the PNS EuroNetwork experience,” J. Neurol. 258(11): 2058–68.CrossRefGoogle ScholarPubMed
Vigliani, M. C., Palmucci, L., Polo, P., Mutani, R., Schiffer, D., De Luca, S., et al. (2001). “Paraneoplastic opsoclonus-myoclonus associated with renal cell carcinoma and responsive to tumour ablation,” J. Neurol. Neurosurg. Psychiatry 70(6): 814–15.CrossRefGoogle Scholar
Walters, A. S. (1995). “Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group,” Mov. Disord. 10(5): 634–42.CrossRefGoogle Scholar
Walker, S., Fine, A., and Kryger, M. H. (1995). “Sleep complaints are common in a dialysis unit,” Am. J. Kidney Dis. 26(5): 751–6.CrossRefGoogle Scholar
Walker, S. L., Fine, A., and Kryger, M. H. (1996). “L-DOPA/carbidopa for nocturnal movement disorders in uremia,” Sleep 19(3): 214–18.Google ScholarPubMed
Wang, H. C. and Cheng, S. J. (2003). “The syndrome of acute bilateral basal ganglia lesions in diabetic uremic patients,” J. Neurol. 250(8): 948–55.CrossRefGoogle ScholarPubMed
Wang, H. C., Hsu, J. L., and Shen, Y. Y. (2004). “Acute bilateral basal ganglia lesions in patients with diabetic uremia: an FDG-PET study,” Clin. Nucl. Med. 29(8): 475–8.CrossRefGoogle Scholar
Wiebers, D. O., Wilson, D. M., McLeod, R. A., and Goldstein, N. P. (1979). “Renal stones in Wilson’s disease,” Am. J. Med. 67(2): 249–54.CrossRefGoogle ScholarPubMed
Winkelman, J. W., Chertow, G. M., and Lazarus, J. M. (1996). “Restless legs syndrome in end-stage renal disease,” Am. J. Kidney Dis. 28(3): 372–8.CrossRefGoogle ScholarPubMed
Yamada, M., Ohno, S., Okayasu, I., Okeda, R., Hatakeyama, S., Watanabe, H., et al. (1986). “Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain,” Acta Neuropathol. 70(3–4): 273–8.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Movement disorders in renal diseases
    • By Tiago Teodoro, Neurological Clinical Research Unit, Instituto de Medicina Molecular, Lisbon, Portugal, Joaquim J. Ferreira, Neurological Clinical Research Unit, Instituto de Medicina Molecular, and Laboratory of Clinical Pharmacology & Therapeutics, Faculty of Medicine, University of Lisbon, Portugal
  • Edited by Werner Poewe, Joseph Jankovic, Baylor College of Medicine, Texas
  • Book: Movement Disorders in Neurologic and Systemic Disease
  • Online publication: 05 April 2014
  • Chapter DOI: https://doi.org/10.1017/CBO9781139175845.013
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Movement disorders in renal diseases
    • By Tiago Teodoro, Neurological Clinical Research Unit, Instituto de Medicina Molecular, Lisbon, Portugal, Joaquim J. Ferreira, Neurological Clinical Research Unit, Instituto de Medicina Molecular, and Laboratory of Clinical Pharmacology & Therapeutics, Faculty of Medicine, University of Lisbon, Portugal
  • Edited by Werner Poewe, Joseph Jankovic, Baylor College of Medicine, Texas
  • Book: Movement Disorders in Neurologic and Systemic Disease
  • Online publication: 05 April 2014
  • Chapter DOI: https://doi.org/10.1017/CBO9781139175845.013
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Movement disorders in renal diseases
    • By Tiago Teodoro, Neurological Clinical Research Unit, Instituto de Medicina Molecular, Lisbon, Portugal, Joaquim J. Ferreira, Neurological Clinical Research Unit, Instituto de Medicina Molecular, and Laboratory of Clinical Pharmacology & Therapeutics, Faculty of Medicine, University of Lisbon, Portugal
  • Edited by Werner Poewe, Joseph Jankovic, Baylor College of Medicine, Texas
  • Book: Movement Disorders in Neurologic and Systemic Disease
  • Online publication: 05 April 2014
  • Chapter DOI: https://doi.org/10.1017/CBO9781139175845.013
Available formats
×